Vital signs monitors frequently top the U.S. FDA’s recall list, due to their ability to cause patient harm. In fact, the FDA database includes many reports of non-invasive blood pressure failures, incorrect oxygen values, electrocardiogram (ECG) signal errors, and more. This compounds the importance of ensuring patient monitoring systems are accurate and safe to use.
According to a new report, the global medical gas and equipment market is slated to surge from its current $14 billion valuation to $20 billion by 2023, increasing at a CAGR of 6.2%. The major factors driving market growth include an aging population and the growing home healthcare market.